Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema
Clinical trial NCT03240133 · COMPLETED
Trial details
- NCT number
- NCT03240133
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2019-01-29
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.